Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 21
Phase 31

Trial Status

Completed2

Role Distribution

Principal Investigator2
PI Rate100%

Activity Timeline

Clinical Trials (2)

NCT06348173Completed
Response and Remission to Treatment With Anti-IL5/IL5R Antagonists
Asthma
PrincipalinvestigatorStart date: 2023-06-01
NCT02049294Phase 2/3Completed
Study of the Steroid Sparing Effect of Xolair (Omalizumab) in Patients With Persistent Eosinophilic Bronchitis
Eosinophilic BronchitisSteroid and/or Prednisone Dependent Asthma
Principalinvestigator

Research Network

Collaboration Network

5 collaborators·10 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

Université de Montréal

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Parameswaran Nair, MD, PhD

McMaster University

Moderately Similar
6 trials

Shared therapeutic areas:

AsthmaEosinophilic BronchitisSteroid and/or Prednisone Dependent Asthma

Worked with same sponsors:

McMaster UniversityNovartis
Collaborated on 1 trial
Similarity Score34%

Delbert Dorscheid, MD

University of British Columbia

Related
1 trials

Shared therapeutic areas:

Eosinophilic BronchitisSteroid and/or Prednisone Dependent Asthma

Worked with same sponsors:

McMaster UniversityNovartis
Collaborated on 1 trial
Similarity Score24%

Richard Leigh, MB

University of Calgary

Related
1 trials

Shared therapeutic areas:

Eosinophilic BronchitisSteroid and/or Prednisone Dependent Asthma

Worked with same sponsors:

McMaster UniversityNovartis
Collaborated on 1 trial
Similarity Score24%

Louis-Philippe Boulet, MD

University of Laval

Related
1 trials

Shared therapeutic areas:

Eosinophilic BronchitisSteroid and/or Prednisone Dependent Asthma

Worked with same sponsors:

McMaster UniversityNovartis
Collaborated on 1 trial
Similarity Score24%

Nikolaos Harokopos, MD

General hospital of Pyrgos, Peloponnese, Greece

Related
1 trials

Shared therapeutic areas:

Asthma
Similarity Score10%

Anastasios Palamidas, MD

Sotiria Pulmonary Hospital of Athens

Related
1 trials

Shared therapeutic areas:

Asthma
Similarity Score10%

Anna Gavriilidou, MD

Papageorgiou hospital of Thessaloniki, Greece

Related
1 trials

Shared therapeutic areas:

Asthma
Similarity Score10%

Ali MA Ismail, lecturer

Cairo University

Related
27 trials

Shared therapeutic areas:

Asthma
Similarity Score10%

Areti Xifteri-Nikolinati, MD

Messini, Greece

Related
1 trials

Shared therapeutic areas:

Asthma
Similarity Score10%

Maria Katertzi, MD

Private office, Moudania, Thessaloniki, Greece

Related
1 trials

Shared therapeutic areas:

Asthma
Similarity Score10%

Publications (0)

No publications found for this investigator.

Clinical Trials (2)

Showing 2 of 2 trials

NCT06348173PrincipalInvestigator

Response and Remission to Treatment With Anti-IL5/IL5R Antagonists

Asthma
Completed
NCT02049294Phase 2/3PrincipalInvestigator

Study of the Steroid Sparing Effect of Xolair (Omalizumab) in Patients With Persistent Eosinophilic Bronchitis

Eosinophilic BronchitisSteroid and/or Prednisone Dependent Asthma
Completed

All 2 trials loaded